Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

BACKGROUND: Ferumoxytol was first approved for clinical use in 2009 solely based on data from trial comparisons with oral iron on biochemical anemia efficacy end points. To compare the rates of important patient outcomes (infection, cardiovascular events and death) between facilities predominantly u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nephrol Dial Transplant
Autors principals: Airy, Medha, Mandayam, Sreedhar, Mitani, Aya A., Chang, Tara I., Ding, Victoria Y., Brookhart, M. Alan, Goldstein, Benjamin A., Winkelmayer, Wolfgang C.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Clinical Science
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829057/
https://ncbi.nlm.nih.gov/pubmed/26311216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv305
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars